I have, and it is lower than FY18.
The FY19 revenue isn't that important IMO
A profitable Q4 and actual bulk orders of Aspirals in Q4 will be.
Then we look to FY20 and beyond.. and that is where the real exciting growth is.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.60M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 886 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 14188 | 1 |
View Market Depth
| Last trade - 10.41am 07/08/2025 (20 minute delay) ? |
| FLC (ASX) Chart |
Day chart unavailable